AI Article Synopsis

  • The study examines the relationship between the Mycobacterium leprae bacterium and the host immune system in leprosy, focusing on how this interaction affects infection outcomes.
  • Dual RNA sequencing of patient lesions reveals two key molecular measures of the bacterium that relate to different host immune responses.
  • These findings enhance our understanding of the mechanisms of inflammation and offer new tools for exploring host-pathogen interactions during infections.

Article Abstract

To understand how the interaction between an intracellular bacterium and the host immune system contributes to outcome at the site of infection, we studied leprosy, a disease that forms a clinical spectrum, in which progressive infection by the intracellular bacterium Mycobacterium leprae is characterized by the production of type I IFNs and antibody production. Dual RNA-seq on patient lesions identifies two independent molecular measures of M. leprae, each of which correlates with distinct aspects of the host immune response. The fraction of bacterial transcripts, reflecting bacterial burden, correlates with a host type I IFN gene signature, known to inhibit antimicrobial responses. Second, the bacterial mRNA:rRNA ratio, reflecting bacterial viability, links bacterial heat shock proteins with the BAFF-BCMA host antibody response pathway. Our findings provide a platform for the interrogation of host and pathogen transcriptomes at the site of infection, allowing insight into mechanisms of inflammation in human disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6508871PMC
http://dx.doi.org/10.1016/j.celrep.2019.02.109DOI Listing

Publication Analysis

Top Keywords

host immune
12
dual rna-seq
8
lesions identifies
8
immune response
8
intracellular bacterium
8
site infection
8
reflecting bacterial
8
bacterial
6
host
6
rna-seq human
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!